BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33515618)

  • 1. Highly activated TRAIL
    Jiang Y; Qin S; Wei X; Liu X; Guan J; Zhu H; Chang G; Chen Y; Lu H; Qian J; Wang Z; Shen M; Lin X
    Immunol Lett; 2021 Apr; 232():9-19. PubMed ID: 33515618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired circulating CD56
    Jiang Y; Chen Y; Chen L; Yao W; Guan J; Liu X; Wei X; Lin X
    Hum Immunol; 2020 Jan; 81(1):32-40. PubMed ID: 31735440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
    Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
    Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines elevated in patients with HBV-related acute-on-chronic liver failure promote NK cell mediated cytotoxicity through TRAIL.
    Wan Z; Xie G; Wu Y; Liu F; Xin S; You S; Liu H; Li C; Li D
    Dig Liver Dis; 2016 May; 48(5):528-535. PubMed ID: 26860239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD56
    Shi A; Zhang X; Xiao F; Zhu L; Yan W; Han M; Luo X; Chen T; Ning Q
    J Viral Hepat; 2018 Nov; 25(11):1352-1362. PubMed ID: 29888839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Killer Group 2A Expressed on Both Peripheral CD3
    Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR
    J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower number and decreased function of natural killer cells in hepatitis B virus related acute-on-chronic liver failure.
    Liu F; Duan X; Wan Z; Zang H; You S; Yang R; Liu H; Li D; Li J; Zhang Y; Xin S
    Clin Res Hepatol Gastroenterol; 2016 Nov; 40(5):605-613. PubMed ID: 27053076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B.
    Wijaya RS; Read SA; Schibeci S; Eslam M; Azardaryany MK; El-Khobar K; van der Poorten D; Lin R; Yuen L; Lam V; George J; Douglas MW; Ahlenstiel G
    J Hepatol; 2019 Aug; 71(2):252-264. PubMed ID: 30905683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir.
    Stelma F; de Niet A; Tempelmans Plat-Sinnige MJ; Jansen L; Takkenberg RB; Reesink HW; Kootstra NA; van Leeuwen EM
    J Infect Dis; 2015 Oct; 212(7):1042-51. PubMed ID: 25791117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CXCR3(+)CD56Bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C.
    Eisenhardt M; Glässner A; Krämer B; Körner C; Sibbing B; Kokordelis P; Nischalke HD; Sauerbruch T; Spengler U; Nattermann J
    PLoS One; 2012; 7(7):e38846. PubMed ID: 22792160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation and altered function of natural killer cells in hepatitis B virus patients treated with entecavir.
    Zhao PW; Jia FY; Shan YX; Ji HF; Feng JY; Niu JQ; Ayana DA; Jiang YF
    Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):190-6. PubMed ID: 23278368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatectomy leads to loss of TRAIL-expressing liver NK cells via downregulation of the CXCL9-CXCR3 axis in mice.
    Yano T; Ohira M; Nakano R; Tanaka Y; Ohdan H
    PLoS One; 2017; 12(10):e0186997. PubMed ID: 29088306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imbalance between CD56+bright and CD56+dim natural killer cell subsets in the liver of patients with recurrent hepatitis C after liver transplantation.
    Yamagiwa S; Sato Y; Ichida T; Setsu T; Tominaga K; Kamimura H; Tsuchiya A; Takamura M; Matsuda Y; Aoyagi Y
    Biomed Res; 2014; 35(3):177-84. PubMed ID: 24942856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis.
    Lima M; Almeida J; Montero AG; Teixeira Mdos A; Queirós ML; Santos AH; Balanzategui A; Estevinho A; Algueró Mdel C; Barcena P; Fonseca S; Amorim ML; Cabeda JM; Pinho L; Gonzalez M; San Miguel J; Justiça B; Orfão A
    Am J Pathol; 2004 Oct; 165(4):1117-27. PubMed ID: 15466379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A.
    Nielsen N; Ødum N; Ursø B; Lanier LL; Spee P
    PLoS One; 2012; 7(2):e31959. PubMed ID: 22384114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reduced frequency of natural killer cell on siglec-7(+) is associated with progression of hepatitis B virus-related cirrhosis].
    Li YL; Zhang QF; Yin WW; Zhang DZ
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):420-425. PubMed ID: 30317754
    [No Abstract]   [Full Text] [Related]  

  • 17. Monocytes inhibit hepatitis C virus-induced TRAIL expression on CD56
    Mele D; Mantovani S; Oliviero B; Grossi G; Lombardi A; Mondelli MU; Varchetta S
    J Hepatol; 2017 Dec; 67(6):1148-1156. PubMed ID: 28803951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional restoration of CD56
    Chen T; Zhu L; Shi A; Ding L; Zhang X; Tan Z; Guo W; Yan W; Han M; Jia J; Luo X; Schuppan D; Ning Q
    Hepatol Int; 2017 Sep; 11(5):419-428. PubMed ID: 28639033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of circulating CD56
    Liu N; Liu B; Zhang L; Li H; Chen Z; Luo A; Chen M; Peng M; Yin W; Ren H; Hu P
    Int Immunopharmacol; 2018 Sep; 62():59-66. PubMed ID: 29990695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.
    Stegmann KA; Björkström NK; Veber H; Ciesek S; Riese P; Wiegand J; Hadem J; Suneetha PV; Jaroszewicz J; Wang C; Schlaphoff V; Fytili P; Cornberg M; Manns MP; Geffers R; Pietschmann T; Guzmán CA; Ljunggren HG; Wedemeyer H
    Gastroenterology; 2010 May; 138(5):1885-97. PubMed ID: 20334827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.